INS068
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for INS068, covering 2022-12-21 to 2025-03-13. Get the full timeline:
Most recent: Clinical Trial Update: To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin. [Phase 3]